PUBLISHER: IMARC | PRODUCT CODE: 1467925
PUBLISHER: IMARC | PRODUCT CODE: 1467925
The global mother and child healthcare market size reached US$ 808.8 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 2,212.7 Billion by 2032, exhibiting a growth rate (CAGR) of 11.6% during 2024-2032.
Mother and child healthcare (MCH) refers to medical services provided to children, adolescents and pregnant women. It includes birthing, fertility, child nutrition, prenatal and postnatal services. MCH emphasizes on preventive, curative, promotive and rehabilitative healthcare services that assist in promoting health, child nutrition and preventing medical ailments to reduce infant and maternal mortality. MCH aids in reducing morbidity and mortality due to unsafe abortions, levels of unwanted and unplanned pregnancies, female genital mutilation, risks of developing cervical cancer and enhancing reproductive health awareness among children. MCH also prevents malnutrition and infection among mothers and children and provides primary health care services.
Significant growth in the healthcare industry is one of the key factors creating a positive outlook for the market. MCH is widely adopted by parents to seek consultation from super-specialist doctors and ensure the good health of both mother and child. Additionally, the widespread adoption of MCH services by pregnant women due to insufficient or no availability of prenatal care and delivery without assistance from appropriately trained health care providers is favoring the market growth. Moreover, the development of various nutritional and micronutrient supplementation strategies that include zinc, calcium, iron and early prenatal food supplementation is providing a thrust to the market growth. These supplements provide essential nutrients in the required quantities and protect the mother and child from infections and diseases. In line with this, the easy availability of digitized claim processing and healthcare policy management solutions is positively impacting the market growth. Other factors, including the increasing number of women suffering from immunodeficiency virus and other chronic illnesses, along with the implementation of various government initiatives to improve public health, are anticipated to drive the market toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global mother and child healthcare market report, along with forecasts at the global, regional and country level from 2024-2032. Our report has categorized the market based on services, maternal age and location.
Pre-Natal Services
Birthing Services
Post-Natal Services
Fertility Services
Under 20 Years
Hospitals
Nursing Homes and Clinics
In-home Services
Others
North America
United States
Canada
Asia-Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa
The competitive landscape of the industry has also been examined along with the profiles of the key players being Ann & Robert Lurie Children's Hospital, Apollo Hospitals Enterprise Ltd., Arrowhead Regional Medical Center, Carle Foundation Hospital, ChristianaCare Christiana Hospital, Cincinnati Children's Hospital, Cleveland Clinic Institute, Cloudnine Group of Hospitals, King Faisal Specialist Hospital & Research Centre, Riley Hospital and The Jorvi Hospital.